Literature DB >> 23422394

Genetic analysis of a population heavy drinking phenotype identifies risk variants in whites.

Ajna Hamidovic1, Robert J Goodloe, Taylor R Young, Mindi A Styn, Kenneth J Mukamal, Helene Choquet, Jay L Kasberger, Sarah G Buxbaum, George J Papanicolaou, Wendy White, Kelly Volcik, Bonnie Spring, Brian Hitsman, Daniel Levy, Eric Jorgenson.   

Abstract

Genetic association studies thus far have used detailed diagnoses of alcoholism to identify loci associated with risk. This proof-of-concept analysis examined whether population data of lifetime heaviest alcohol consumption may be used to identify genetic loci that modulate risk. We conducted a genetic association study in European Americans between variants in approximately 2100 genes and alcohol consumption as part of the Candidate gene Association Resource project. We defined cases as individuals with a history of drinking 5 or more drinks per day almost every day of the week and controls as current light drinkers (1-5 drinks per week). We cross-validated identified single nucleotide polymorphisms in a meta-analysis of 2 cohorts of unrelated individuals--Atherosclerosis Risk in Communities (ARIC) and Cardiovascular Health Study (CHS)--and in a separate cohort of related individuals--Framingham Heart Study (FHS). The most significant variant in the meta-analysis of ARIC and CHS was rs6933598 in methylenetetrahydrofolate dehydrogenase (P = 7.46 × 10(-05)) with a P value in FHS of 0.042. The top variants in FHS were rs12249562 in cubulin (P = 3.03 × 10(-05)) and rs9839267 near cholecystokinin (P = 3.05 × 10(-05)) with a P value of 0.019 for rs9839267 in CHS. We have here shown feasibility in evaluating lifetime incidence of heavy alcohol drinking from population-based studies for the purpose of conducting genetic association analyses.

Entities:  

Mesh:

Year:  2013        PMID: 23422394      PMCID: PMC4339794          DOI: 10.1097/JCP.0b013e318287009a

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  51 in total

1.  No association between C-45T polymorphism in the Sp1 binding site of the promoter region of the cholecystokinin gene and alcoholism.

Authors:  H Ishiguro; T Saito; H Shibuya; M Toru; T Arinami
Journal:  Psychiatry Res       Date:  1999-02-22       Impact factor: 3.222

2.  Genetic and environmental contributions to alcohol abuse and dependence in a population-based sample of male twins.

Authors:  C A Prescott; K S Kendler
Journal:  Am J Psychiatry       Date:  1999-01       Impact factor: 18.112

3.  The Cardiovascular Health Study: design and rationale.

Authors:  L P Fried; N O Borhani; P Enright; C D Furberg; J M Gardin; R A Kronmal; L H Kuller; T A Manolio; M B Mittelmark; A Newman
Journal:  Ann Epidemiol       Date:  1991-02       Impact factor: 3.797

4.  Hyperhomocysteinemia in chronic alcoholism: correlation with folate, vitamin B-12, and vitamin B-6 status.

Authors:  M L Cravo; L M Glória; J Selhub; M R Nadeau; M E Camilo; M P Resende; J N Cardoso; C N Leitão; F C Mira
Journal:  Am J Clin Nutr       Date:  1996-02       Impact factor: 7.045

5.  Genetic and environmental contributions to alcohol dependence risk in a national twin sample: consistency of findings in women and men.

Authors:  A C Heath; K K Bucholz; P A Madden; S H Dinwiddie; W S Slutske; L J Bierut; D J Statham; M P Dunne; J B Whitfield; N G Martin
Journal:  Psychol Med       Date:  1997-11       Impact factor: 7.723

6.  Genetic and environmental influences on lifetime alcohol-related problems in a volunteer sample of older twins.

Authors:  C A Prescott; J K Hewitt; K R Truett; A C Heath; M C Neale; L J Eaves
Journal:  J Stud Alcohol       Date:  1994-03

7.  A new genetic variant in the Sp1 binding cis-element of cholecystokinin gene promoter region and relationship to alcoholism.

Authors:  S Harada; T Okubo; M Tsutsumi; S Takase; T Muramatsu
Journal:  Alcohol Clin Exp Res       Date:  1998-05       Impact factor: 3.455

8.  Dementia revealed: novel chromosome 6 locus for late-onset Alzheimer disease provides genetic evidence for folate-pathway abnormalities.

Authors:  Adam C Naj; Gary W Beecham; Eden R Martin; Paul J Gallins; Eric H Powell; Ioanna Konidari; Patrice L Whitehead; Guiqing Cai; Vahram Haroutunian; William K Scott; Jeffery M Vance; Michael A Slifer; Harry E Gwirtsman; John R Gilbert; Jonathan L Haines; Joseph D Buxbaum; Margaret A Pericak-Vance
Journal:  PLoS Genet       Date:  2010-09-23       Impact factor: 5.917

Review 9.  Neurobiology of cholecystokinin.

Authors:  T H Moran; G J Schwartz
Journal:  Crit Rev Neurobiol       Date:  1994

10.  The role of cholecystokinin (CCK), CCK-A or CCK-B receptor antagonists in the spontaneous preference for drugs of abuse (alcohol or cocaine) in naive rats.

Authors:  F Crespi
Journal:  Methods Find Exp Clin Pharmacol       Date:  1998-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.